Evidence map›Paper›PMID 40783995›Full record

ArticleJoint diseases and related surgery2025

The efficiency of ozone therapy in the prevention of heterotopic bone formation in an animal model.

Özgür Doğan Aydın, Tayfun Bacaksız, İhsan Akan, Aysu Hayriye Tezcan, Tuğrul Bulut, Cemal Kazimoglu

Abstract read
In one paragraph

Article in Joint diseases and related surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Özgür Doğan Aydınİzmir Şehir Hastanesi, Ortopedi ve Travmatoloji Kliniği, 35540 Bayraklı, İzmir, Türkiye. aydinozgurdogan@gmail.com.
Tayfun Bacaksız
İhsan Akan
Aysu Hayriye Tezcan
Tuğrul Bulut
Cemal Kazimoglu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesIn our study, we aimed to evaluate the efficacy of prophylactic ozone therapy (OT) for heterotopic ossification (HO) development after hip surgery in a rat model. MATERIALS AND

methodsWe randomly divided a total of 20 Wistar albino rats into two equal groups (n=10) as the control group (Group 1) receiving daily intraperitoneal injections of 1 mL of Ringer's lactate solution for a duration of two weeks after undergoing hip surgery and the group (Group 2) receiving OT daily at a dose of 1 mL of an ozone/oxygen combination via intraperitoneal route for a period of two weeks after hip surgery. Hip surgery was performed to mimic the formation of HO. After 12 weeks, the animals were evaluated functionally and sacrificed. Following sacrification, histopathological, and radiological assessments were performed.

resultsThe modified Brooker staging method was used for radiological evaluation, and all animals in the control group showed at least Stage 1 HO formation. However, only three animals (30%) in the OT group showed HO formation (p=0.006). In histopathological evaluation, the median HO rates in the high power field were 42.5 (range, 30 to 55) in the control group and 0 (range, 0 to 25) in the OT group (p=0.003), and the median leukocyte count was 5.5 (range, 3 to 7) in the control group and 1 (range, 0 to 3) in the ozone group (p=0.006). Radiological HO, histopathological HO, and inflammation were significantly lower in the ozone group (p<0.05).

conclusionOur study results suggest that OT is effective in decreasing HO formation in rats following hip surgery.

Indexed as

Ossification, HeterotopicOzoneAnimalsDisease Models, AnimalInjections, IntraperitonealMaleRadiographyRatsRats, WistarOzone

Identifiers

PMID40783995
PMCPMC12456343

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.